TR199900140T2 - 5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi. - Google Patents
5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi.Info
- Publication number
- TR199900140T2 TR199900140T2 TR1999/00140T TR9900140T TR199900140T2 TR 199900140 T2 TR199900140 T2 TR 199900140T2 TR 1999/00140 T TR1999/00140 T TR 1999/00140T TR 9900140 T TR9900140 T TR 9900140T TR 199900140 T2 TR199900140 T2 TR 199900140T2
- Authority
- TR
- Turkey
- Prior art keywords
- antagonist
- 5ht2c
- pharmaceutical composition
- compounds
- activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9615767.2A GB9615767D0 (en) | 1996-07-26 | 1996-07-26 | Novel treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199900140T2 true TR199900140T2 (xx) | 1999-03-22 |
Family
ID=10797573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/00140T TR199900140T2 (xx) | 1996-07-26 | 1997-07-22 | 5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi. |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0936924A2 (es) |
JP (1) | JP2000516924A (es) |
KR (1) | KR20000029564A (es) |
CN (1) | CN1230894A (es) |
AR (1) | AR008083A1 (es) |
AU (1) | AU725817B2 (es) |
BR (1) | BR9710568A (es) |
CA (1) | CA2261813A1 (es) |
CO (1) | CO5031292A1 (es) |
CZ (1) | CZ23799A3 (es) |
GB (1) | GB9615767D0 (es) |
HU (1) | HUP9903619A3 (es) |
IL (1) | IL128219A0 (es) |
NO (1) | NO990322L (es) |
NZ (1) | NZ333813A (es) |
PL (1) | PL331426A1 (es) |
TR (1) | TR199900140T2 (es) |
WO (1) | WO1998004289A2 (es) |
ZA (1) | ZA976593B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9612883D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
JP2002530339A (ja) | 1998-11-23 | 2002-09-17 | セプラコール, インク. | 2−ヒドロキシメチルオランザピン組成物及び方法 |
US6121259A (en) * | 1998-11-23 | 2000-09-19 | Sepracor Inc. | Olanzapine-N-oxide compositions and methods |
EP1133300B1 (en) | 1998-11-23 | 2005-01-05 | Sepracor Inc. | Desmethylolanzapine compositions and methods |
EP1165090A2 (en) * | 1999-03-18 | 2002-01-02 | Children's Hospital Research Foundation | A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications |
JP2003500353A (ja) * | 1999-05-19 | 2003-01-07 | アストラゼネカ・アクチエボラーグ | 処置方法 |
WO2005013969A1 (en) * | 2003-07-15 | 2005-02-17 | Janssen Pharmaceutica N.V. | Antipsychotic agent with socializing properties |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9500998D0 (sv) * | 1995-03-19 | 1995-03-19 | Haakan Wilhelm Wikstroem | New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics |
-
1996
- 1996-07-26 GB GBGB9615767.2A patent/GB9615767D0/en active Pending
-
1997
- 1997-07-22 CA CA002261813A patent/CA2261813A1/en not_active Abandoned
- 1997-07-22 CN CN97197977A patent/CN1230894A/zh active Pending
- 1997-07-22 WO PCT/EP1997/004159 patent/WO1998004289A2/en not_active Application Discontinuation
- 1997-07-22 HU HU9903619A patent/HUP9903619A3/hu unknown
- 1997-07-22 EP EP97918947A patent/EP0936924A2/en not_active Ceased
- 1997-07-22 JP JP10508522A patent/JP2000516924A/ja active Pending
- 1997-07-22 BR BR9710568A patent/BR9710568A/pt not_active Application Discontinuation
- 1997-07-22 CZ CZ99237A patent/CZ23799A3/cs unknown
- 1997-07-22 TR TR1999/00140T patent/TR199900140T2/xx unknown
- 1997-07-22 IL IL12821997A patent/IL128219A0/xx unknown
- 1997-07-22 KR KR1019997000622A patent/KR20000029564A/ko not_active Application Discontinuation
- 1997-07-22 PL PL97331426A patent/PL331426A1/xx unknown
- 1997-07-22 AU AU42972/97A patent/AU725817B2/en not_active Ceased
- 1997-07-22 NZ NZ333813A patent/NZ333813A/xx unknown
- 1997-07-24 AR ARP970103348A patent/AR008083A1/es not_active Application Discontinuation
- 1997-07-24 ZA ZA976593A patent/ZA976593B/xx unknown
- 1997-07-25 CO CO97042582A patent/CO5031292A1/es unknown
-
1999
- 1999-01-25 NO NO990322A patent/NO990322L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL128219A0 (en) | 1999-11-30 |
CO5031292A1 (es) | 2001-04-27 |
CZ23799A3 (cs) | 1999-06-16 |
ZA976593B (en) | 1999-01-25 |
HUP9903619A2 (hu) | 2000-10-28 |
BR9710568A (pt) | 1999-08-17 |
AR008083A1 (es) | 1999-12-09 |
KR20000029564A (ko) | 2000-05-25 |
JP2000516924A (ja) | 2000-12-19 |
WO1998004289A3 (en) | 1998-03-19 |
CN1230894A (zh) | 1999-10-06 |
NZ333813A (en) | 2000-07-28 |
PL331426A1 (en) | 1999-07-19 |
CA2261813A1 (en) | 1998-02-05 |
AU725817B2 (en) | 2000-10-19 |
NO990322D0 (no) | 1999-01-25 |
GB9615767D0 (en) | 1996-09-04 |
AU4297297A (en) | 1998-02-20 |
HUP9903619A3 (en) | 2001-03-28 |
NO990322L (no) | 1999-03-24 |
WO1998004289A2 (en) | 1998-02-05 |
EP0936924A2 (en) | 1999-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
TR199802284T2 (xx) | Dopamin D3 resept�rlerinin mod�lat�rleri olarak tetrahidroizokuinolin t�revleri. | |
PT935465E (pt) | Compostos novos de imidazole substituido | |
TR199902033T2 (xx) | Diyabet i�in s�lfonilura-glitazon sinerjik kombinasyonlar�. | |
TR200001218T2 (tr) | İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler. | |
FI962154A (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
TR199802423T2 (xx) | Konsantre antikor terkibi. | |
ES2184800T3 (es) | Uso de agentes anti-vegf en el tratamiento de la endometriosis. | |
UA41316C2 (uk) | Трициклічні похідні піролу і фармацевтичний препарат | |
PT1093819E (pt) | Compostos e composicoes para fornecimento de agentes activos | |
DE69501591D1 (de) | Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung | |
ES2190246T3 (es) | Nuevos compuestos de tiazolopirimidina. | |
PT839143E (pt) | Compostos de tetralina com actividade mdr | |
TR199902334T2 (xx) | Psikotik bozukluklar�n tedavisi veya profilaksisi i�in mirtazapin ve antipsikotik ajanlar�n yeni terap�tik kombinasyonlar�. | |
BR9909486A (pt) | Compostos calcilìticos | |
DE69522188T2 (de) | Verwendung von Substanz P Antagonist im pharmazeutischer Zusammensetzung | |
TR199900140T2 (xx) | 5HT2C antagonist ve bir D2 antagonist ihtiva eden farmas�tik bile�imi. | |
PT101444A (pt) | Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao | |
TR199900872T1 (xx) | Bir heteroetinilen radikali ile ba�l� bi-aromatik bile�ikler ve bunlar� ihtiva eden farmas�tik ve kozmetik kompozisyonlar. | |
CL2002001701A1 (es) | Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno. | |
ATE332728T1 (de) | Photoempfindliche sonnenschutzmittel | |
TR200102944T2 (tr) | İntegrin reseptör ligandları | |
ATE199641T1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
PL339073A1 (en) | Derivatives of benzoxazine and benzothiazine and their application in therapeutic agents | |
TR200103090T2 (tr) | Integrın reseptör antagonistleri |